BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30149104)

  • 1. Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts.
    Birkenfeld AL; Jordan J; Dworak M; Merkel T; Burnstock G
    Pharmacol Ther; 2019 Feb; 194():132-144. PubMed ID: 30149104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Selvaraj S; Kelly DP; Margulies KB
    Circulation; 2020 Jun; 141(22):1800-1812. PubMed ID: 32479196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac metabolism in heart failure: implications beyond ATP production.
    Doenst T; Nguyen TD; Abel ED
    Circ Res; 2013 Aug; 113(6):709-24. PubMed ID: 23989714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction.
    Fillmore N; Levasseur JL; Fukushima A; Wagg CS; Wang W; Dyck JRB; Lopaschuk GD
    Mol Med; 2018 Mar; 24(1):3. PubMed ID: 30134787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketone body metabolism in diabetic and non-diabetic heart failure.
    Qian N; Wang Y
    Heart Fail Rev; 2020 Sep; 25(5):817-822. PubMed ID: 31612363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic therapy of heart failure.
    Fragasso G; Salerno A; Spoladore R; Bassanelli G; Arioli F; Margonato A
    Curr Pharm Des; 2008; 14(25):2582-91. PubMed ID: 18991675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Kärkkäinen O; Tuomainen T; Mutikainen M; Lehtonen M; Ruas JL; Hanhineva K; Tavi P
    Cardiovasc Res; 2019 Jan; 115(1):107-118. PubMed ID: 29931052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.
    Hunter WG; Kelly JP; McGarrah RW; Kraus WE; Shah SH
    Curr Heart Fail Rep; 2016 Jun; 13(3):119-31. PubMed ID: 27216948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potential implications of ketone body metabolism changes and ketogenic therapy in the treatment of heart failure].
    Wang Q; Yan S; Kuang S; Zhou M; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):769-772. PubMed ID: 37545460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese medicine enhances myocardial metabolism during heart failure.
    Shao-Mei W; Li-Fang Y; Li-Hong W
    Biomed Pharmacother; 2022 Feb; 146():112538. PubMed ID: 34922111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heart metabolism: pathophysiological aspects in ischaemia and heart failure.
    Abozguia K; Shivu GN; Ahmed I; Phan TT; Frenneaux MP
    Curr Pharm Des; 2009; 15(8):827-35. PubMed ID: 19275646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
    Honka H; Solis-Herrera C; Triplitt C; Norton L; Butler J; DeFronzo RA
    J Am Coll Cardiol; 2021 Apr; 77(16):2022-2039. PubMed ID: 33888253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic remodelling in human heart failure.
    Tuunanen H; Knuuti J
    Cardiovasc Res; 2011 May; 90(2):251-7. PubMed ID: 21372005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
    Fukushima A; Lopaschuk GD
    Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR; Chen S; Welsh A; Tang WHW; Nguyen CT
    Curr Heart Fail Rep; 2022 Aug; 19(4):180-190. PubMed ID: 35567658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure.
    Meng S; Yu Y; Yu S; Zhu S; Shi M; Xiang M; Ma H
    J Cardiovasc Transl Res; 2024 Feb; 17(1):36-55. PubMed ID: 37843752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.